Data di Pubblicazione:
2023
Citazione:
Immunotherapy / Viscardi, G.; Russo, G. L.; Ferrara, R.; Garassino, M. C.. - (2023), pp. 283-304. [10.1016/B978-0-323-69573-2.00022-X]
Abstract:
This chapter explores the different CTLA-4, PD-1 and PD-L1 inhibitors that have been investigated in advanced NSCLC, analyzing the different studies that have been performed, the evidences obtained, and the role in the clinical management of patients.
Tipologia CRIS:
2.1 Contributo in volume (Capitolo o Saggio)
Elenco autori:
Viscardi, G.; Russo, G. L.; Ferrara, R.; Garassino, M. C.
Link alla scheda completa:
Titolo del libro:
Lung Cancer: an Evidence-Based Approach to Multidisciplinary Management